Sveiko stuburo studija, MB - financials and debts

Company age: 3 y. 8 mo.

Update

Sveiko stuburo studija - Company finances

EUR
2023
From: 2023-01-25
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 23,948 11,596 8,641
Profit before tax 800 -739 -56
Net profit 800 -739 -56
Equity 800 61 4
Liabilities 23,948 0 0
Non-current assets 0 0 0
Current assets 24,748 61 4
Total assets 24,748 61 4
Taxes paid
STI taxes - 40 -
Financial indicators
Revenue change y/y - -51.6% -25.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 3.2% -1211.5% -1400.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 100.0% -1211.5% -1400.0%
Profit margin Net profit margin. Shows the overall profitability of the company. 3.3% -6.4% -0.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 3.3% -6.4% -0.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 29.9 - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Sveiko stuburo studija - Social security debts

From To Debt, €
2025-10-15 2025-10-31 7.64
2025-10-14 2025-10-14 85.62
2025-09-02 2025-10-13 217.35
2025-08-01 2025-09-01 144.90
2025-07-01 2025-07-31 72.45
2025-05-04 2025-05-31 357.01
2025-04-03 2025-04-30 104.63

Sveiko stuburo studija - VMI tax arrears

From To Overdue, €
2026-02-21 2026-02-21 7.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Sveiko stuburo studija, MB (code 306232581) is a small partnership engaged in physiotherapy activities. In the latest financial year, 2025, revenue amounted to €8.6K, which was 25.5% lower than in 2024 and 63.9% below the 2023 level. Net profit for 2025 was -€56, following a loss of -€739 in 2024 and a profit of €800 in 2023, indicating a clear weakening in profitability over the three-year period. The 2025 profit margin stood at -0.6%. The balance sheet was very small at year-end 2025, with total assets and equity both at €4. In 2024, assets and equity had already declined to €61, after €24.7K of assets and €800 of equity in 2023. Liabilities were €23.9K in 2023. With such a minimal asset and equity base in 2025, return ratios and turnover indicators should be interpreted with caution. Overall, the company remained active, but both revenue and earnings trended downward across 2023-2025.